Name

Conceive

Legal name

Conceive Inc

Website

https://weconceive.com

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Fertility and Reproductive Health Services

NAICS

Educational Support Services (61171)

SIC

Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Fertility & Reproductive Endocrinology Telehealth (IVF/IUI, infertility evaluation) (HLALAHAA)

akta.pro secondary industries

Pregnancy & Prenatal Care Telehealth (OB tele-visits, prenatal monitoring) (HLALAHAC), Family Care Navigation & Care Coordination Platforms (multi-member care plans, referrals) (HLALAHAL), Maternal Mental Health Telehealth (perinatal anxiety/depression, support programs) (HLALAHAH), Prenatal, Postpartum & Fertility Nutrition (HSADAFAK)

Keywords

• Fertility care platform
• Digital health services
• Reproductive health support
• Fertility coaching
• Pregnancy care

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Others

Revenue model

1. Subscription Membership - Conceive Plus: Monthly subscription at $43-49/month providing fertility coaching, 24/7 text support, expert articles, and referrals to specialists. Includes 2-week free trial.
2. Subscription Membership - Conceive Premium: Premium tier at $116-129/month adding monthly 1:1 video calls with nurses/coaches/dietitians, community events, financial coaching, and member-only sessions. Builds on Plus tier.
3. One-time Diagnostic Testing: Fertility testing products including Semen Analysis ($295), Women's Basic Fertility Test ($175), Women's Advanced Fertility Test ($285), Men's Fertility Blood Test ($104), Ovulation Confirmation ($129), and Pregnancy Test ($104). All include video consultation with fertility nurse.
4. GLP-1 Weight Loss Program Membership: $115/month membership for medically-guided GLP-1 weight treatment designed for fertility patients. Includes 24/7 text support, clinician oversight, dietitian sessions. Medication paid separately.

Pricing tiers

Go-to-market motion3 records

Distribution channels3 records

Marketing channels7 records

Core offering

Conceive provides subscription-based, 24/7 text-based access to fertility and pregnancy nurses, coaches, and dietitians, paired with peer community matching and evidence-based educational content. The platform also sells at-home and lab-based fertility diagnostic tests for women and men and operates a GLP-1 weight management program tailored to fertility patients. A B2B Clinic Partner Program extends Conceive support to fertility clinics and OB-GYN practices.

Product overview

Conceive is a digital health platform offering a subscription-based care model structured around tiered memberships (Conceive Plus and Conceive Premium) providing 24/7 access to fertility nurses, coaches, and peer communities. The platform complements its core membership programs with ancillary products including at-home and lab-based fertility testing (for women and men), a GLP-1 weight management program, and B2B clinic partner solutions. Testing products include Women's Basic/Advanced Fertility Tests, Semen Analysis (via Legacy partnership), Men's Fertility Blood Test, Ovulation Confirmation, and Pregnancy Test. The GLP-1 Program and Clinic Partner Programs serve both direct consumers and fertility clinic partners.

Differentiator

Problem solved

Functional benefit

Products and services

• Conceive Plus Entry-level monthly subscription offering personalized fertility coaching, 24/7 text support from fertility and pregnancy nurses, coaches, and dietitians, expert-reviewed articles, and referrals to fertility specialists. Starting at $43/month with a 2-week free trial.
• Conceive Premium Premium monthly subscription including all Plus features plus monthly 1:1 video calls with fertility, L&D, OB, or NICU nurses/coaches/dietitians, virtual expert events, Conceive community access, member-only sessions, and early access to new products. Starting at $116/month.
• Women's Basic Fertility Test Lab-based hormone panel measuring AMH, FSH, LH, estradiol, and TSH to evaluate ovarian reserve and reproductive health, with a video consultation with a fertility nurse to review results. Priced at $175, HSA/FSA eligible.
• Women's Advanced Fertility Test Comprehensive fertility panel including all Basic tests plus prolactin, vitamin D, CBC, blood type, infectious disease screening, and immunity screening for Rubella and Varicella. Priced at $285, includes video consultation.
• Semen Analysis At-home semen analysis delivered via partnership with Legacy, testing volume, concentration, motility, morphology, and DNA fragmentation. Discreet kit shipping, prepaid return, and results delivered within 3 business days. Priced at $295, HSA/FSA eligible.
• Men's Fertility Blood Test Lab-based hormone and infectious disease screening for men, including testosterone evaluation and STI screening for HIV, Hepatitis B/C, Syphilis, and Gonorrhea/Chlamydia. Priced at $104, HSA/FSA eligible.
• Ovulation Confirmation Lab-based test confirming ovulation through progesterone, estradiol, and LH surge detection for individuals trying to conceive with timed intercourse. Priced at $129, HSA/FSA eligible.
• Pregnancy Test Blood-based pregnancy confirmation measuring hCG and progesterone for early and accurate detection. Priced at $104, HSA/FSA eligible. Available in NY/NJ only via BioReference.
• GLP-1 Program (Consumer) Temporary, medically guided GLP-1 weight management program designed for fertility patients, including clinician-led prescription, dose titration, monthly check-ins, 24/7 guidance, nutrition support, and a planned transition before conception or IVF. $115/month plus separate medication costs; HSA/FSA eligible.
• Clinic Partner Program (Fertility) B2B offering for fertility clinics and OB-GYN practices that extends 24/7 text, call, and video access to fertility nurses, curated community groups, and technology reinforcing clinic SOPs, aimed at reducing clinician burnout and improving patient retention.
• GLP-1 Program for Clinics B2B GLP-1 weight optimization program for fertility clinics that manages patient prescribing, titration, nutrition support, and progress tracking toward BMI and treatment-readiness criteria, with structured handoff back to the clinic for fertility treatment.

Quantifiable outcome

• 61% of members become pregnant within six months of joining
• +11 more outcomes

Named customers5 records

Segments5 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Four partnerships are on record, tiered core and major.

• LegacycoreTechnology or IntegrationPartnership for at-home semen analysis. Legacy ships discrete at-home collection kits, members collect and return samples using prepaid labels, and results are delivered in Conceive dashboard within 3 business days. Unlike other at-home options, Legacy's test includes motility, morphology, and DNA fragmentation analysis.
• LabCorpcoreTechnology or IntegrationPrimary lab partner for fertility testing in 48 states (excluding NY/NJ). Members schedule blood draws at nearby LabCorp locations. Tests include women's fertility panels, men's hormone panels, and infectious disease screening.
• BioReference (NY/NJ)coreTechnology or IntegrationLab partner for New York and New Jersey locations. Provides same STAT testing capabilities for fertility panels, ovulation confirmation, and pregnancy testing.
• RMA of New YorkmajorStrategic or Co-development PartnerMajor fertility clinic partnership. Dr. Alan Copperman, Managing Partner at RMA of New York, provided testimonial endorsing Conceive partnership: 'We are thrilled to partner with Conceive to further enhance the support we provide to our patients.' Pilot program demonstrated significant patient stress reduction and improved sense of control.

Scale indicators9 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Kindbody: Kindbody operates fertility clinics and an employer-facing benefits product combining virtual and in-person reproductive care. It overlaps with Conceive's clinic partnership and B2B distribution strategy while owning clinic assets Conceive does not.
• Tia: Tia is a women's healthcare provider combining in-person clinics with virtual care across gynecology, primary care, and mental health. Several Tia founders are Conceive angel investors, signaling overlapping thesis around integrated women's care journeys.
• Carrot Fertility: Carrot Fertility is a leading fertility and family-forming benefits platform sold to employers and health plans, covering fertility care, preservation, and pregnancy. It directly competes with Conceive's clinic partnership motion and increasingly targets the same member journey.
• Maven Clinic: Maven Clinic is the largest virtual clinic for women's and family health, providing 24/7 care across fertility, pregnancy, postpartum, and pediatrics via coaches, specialists, and on-demand content. It is the closest direct competitor to Conceive with overlapping member journey and B2B employer distribution.

Broad incumbents

• Progyny: Progyny is the largest publicly-traded fertility benefits management company, offering employer-sponsored coverage for IVF, IUI, preservation, and pregnancy. It competes in the same member journey and employer channel but with a managed benefits structure rather than a DTC subscription model.
• Modern Fertility (Ro): Modern Fertility, acquired by Ro, sells at-home hormone testing and reproductive health content direct to consumers. It overlaps with Conceive's lab testing products and educational content but operates within Ro's broader men's/women's health ecosystem.

Emerging players

• Natalist: Natalist sells fertility and pregnancy consumer products (tests, supplements) with strong educational content for people trying to conceive. Its founders are Conceive angel investors, and the brand targets the same trying-to-conceive consumer with adjacent products.
• Oova: Oova offers at-home hormone-based fertility testing with digital tracking and clinician insights, focused on cycle and ovulation monitoring. It is an emerging niche player competing in the same at-home testing and tracking category as Conceive's diagnostic add-ons.
• Mojo (Sandbox Medical): Mojo is a men's fertility platform providing at-home semen analysis, clinician consultations, and coaching. It overlaps with Conceive's men's fertility testing and coaching layer and competes for the male partner audience during fertility journeys.
• Frame Fertility: Frame Fertility is a virtual fertility clinic and emotional support service offering nurse-led guidance, mental health, and community for people trying to conceive. It is a closely comparable emerging peer in the always-on fertility support category.

Market position

Strengths2 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/weconceive

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds2 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Conceive